WDB Holdings, a leading player in the human resource services and Contract Research Organization (CRO) business arenas, will acquire all shares of Cobridge Co., Ltd., as of June 30, 2017, and Cobridge will become a member of the WDB group.
Cobridge will continue its regulatory consulting services, including preparation of application dossiers and serving as Designated Marketing Authorization Holder (DMAH) for overseas pharmaceutical and medical device manufacturers, and also continue to handle DMFs (Drug Master Files) as an ICC (In-Country Caretaker).
As the WDB group expands its CRO business in the future, Cobridge will seek to enhance its ability to meet client needs by leveraging synergies with WDB group’s CRO companies based in Japan, US and EU.
Our company name, location and contact information (e-mail and telephone numbers) will remain unchanged.
We deeply appreciate your continuing support